Related Experiment Video
Updated: Apr 12, 2026

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
Published on: December 18, 2014
Pharmacological disruption of maladaptive memory
Jane R Taylor1, Mary M Torregrossa
1Department of Psychiatry, Yale University, New Haven, CT, USA.
Pharmacological interventions targeting memory reconsolidation offer a novel approach to weaken maladaptive memories. This research explores methods to disrupt intrusive memories in psychiatric disorders like PTSD and addiction.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Maladaptive memories significantly contribute to psychiatric disorders such as posttraumatic stress disorder (PTSD) and addiction.
- These memories can perpetuate illness and impede treatment efficacy, necessitating novel therapeutic strategies.
Purpose of the Study:
- To explore pharmacological methods for weakening the strength of maladaptive memories.
- To identify potential treatments for psychiatric disorders by targeting memory reconsolidation.
Main Methods:
- Review of preclinical and clinical studies on memory reconsolidation.
- Investigation of pharmacological agents that can disrupt the labile state of memory during reconsolidation.
Main Results:
- Memory reconsolidation presents a critical window for pharmacological intervention.
- Preclinical and clinical evidence suggests the feasibility of disrupting maladaptive memory integrity.
Conclusions:
- Targeting memory reconsolidation offers a promising avenue for developing new treatments for psychiatric conditions.
- Pharmacological disruption of maladaptive memories could significantly improve patient outcomes in PTSD and addiction.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Desensitization and Tachyphylaxis
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Drugs Affecting Neurotransmitter Release or Uptake

